ArticleNeuroradiology2020

Conventional magnetic resonance imaging-based radiomic signature predicts telomerase reverse transcriptase promoter mutation status in grade II and III gliomas.

Chendan Jiang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.